- Report
- February 2024
- 115 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- February 2024
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- February 2024
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- February 2024
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 75 Pages
Netherlands
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 113 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 115 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 66 Pages
Australia
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2023
- 75 Pages
South Korea
From €4351EUR$4,750USD£3,698GBP
- Report
- August 2022
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- August 2022
- 111 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- August 2022
- 111 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- August 2022
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- August 2022
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2021
- 115 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2022
- 73 Pages
Global
From €2244EUR$2,450USD£1,907GBP

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more